feed,title,long_url,short_url
ðŸ’°Barrons,This Pharma Stock Had a Rough Year. Why One Analyst Thinks It Can Rise 250%.,https://barrons.com/articles/vaxcyte-stock-mizuho-top-pick-36590a36?mod=RTA,
